The Shared Plug is one Plugboard shared by many sites. Inserting your 88x31 web button into this Plugboard automatically is reflected on all Shared Plugboards over the different sites and in this page (refreshing it). It stays there until it is pushed out by new buttons. It makes for great free plugboard advertising.
The PlugBoard consists of URL links that point to various web sites. Entering ("plugging in" ) your web site Title and web site URL link allows you to promote your site and increase visitor traffic. The number of available spots is fixed. No return link is required, and it's free. You just add the Title of your web site and the URL address of your web site and then press the red Plug button. Remember: the last site to plug in or that enters their web site link pushes out the first one, so come back often to check if your button is still on the Plugboard.
CANADIAN MUSEUM FOR HUMAN RIGHTS — A CALL FOR INCLUSIVENESS, EQUITY AND FAIRNESS
Featured Article #2
The CMHR represents a unique opportunity for Canada to be recognized as a leader in reflecting and further advancing contemporary research on genocide and human rights and in telling the story of all genocides without any attempt to represent the suffering of one nation, tribe or community as having been of more relevance or importance than any other’s. All attempts to do so argue fundamentally do an injustice to the memory of the many millions of victims of genocide throughout the ages, whether they suffered in Europe, or somewhere else.
This article provides you with some basic guidelines, concepts and issues perceived to be important for a proper understanding of item analysis. This pursuit, however, is best appreciated when supplemented with one-on-one or small group mentoring and “real-world” applications, in a safe learning environment.
Welcome to Ukraine! - Co-Host of the UEFA Euro 2012 Cup
Ukraine... The land where all the roads cross and the East meets the West... Reveal the mysterious history of civilizations and cultures of over 10 millennia in every bit of this land!
The Almond Tree Sweetens Up the Market at The Forks
How did Canada get its name? Most Canadians, if asked about the origins of the name “Canada”, will admittedly lament their ignorance of that part of Canadian history. Of those that do remember, they might even recall the “official” version of how Canada got its name, the one they received from the TV commercial “A Part Of Our Heritage – Canada.” After all, Canadian history is not a subject taught in the schools, per se. Education remains in provincial jurisdiction so each region features their preferred understandings of Canada’s history. As such, there are many competing theories on how Canada came to be known and called. All of them fascinating and equally compelling, but only three theories tend to capture the hearts and minds of historians and researchers more so than the others. They are presented here momentarily.
The Montreal Biodome: A Funtastic Family Destination
Featured Article #8 (includes Video)
The Montreal Biodome (Biodôme de Montréal in French) is one of four Nature Museums in one of the most beautiful cities in North America and a great place to visit for a family with children. It has animals, fish, and landscaped gardens. Over 4,800 animals and 750 plant species reside in this oasis. This 100,000 plus square foot museum opened its doors to the public in June of 1992. Over 15 million visitors have already seen this ecological wonderland, 845,000 visitors in 2008 alone.
The goal of Ukrainian Milk Company LLC is to become a leader in milk production sector of Ukraine by establishing a network of dairy farms.
You can have your article featured here for only $5 monthly. Posted will be the article title, author, abstract and hypertext link to your article. To Learn More, See Ad Prices, Option 3: Purchase a Featured Status Article now!
Leader Banner Ad (Header)
Herbal Immunotherapy for Multi-Drug (MDR) and Extensively Drug-Resistant Tuberculosis (XDR-TB) as well as TB with HIV
Herbal Immunotherapy for Multi-Drug (MDR) and Extensively Drug-Resistant Tuberculosis (XDR-TB) as well as TB with HIV
Ukrainian company, Ekomed LLC, published clinical study of phytoconcentrates Dzherelo (Immunoxel), Lizorm and Svitanok used as an adjunct immunotherapy against multi-drug (MDR-TB), (XDR-TB), and in patients with concomitant HIV and Mycobacterium tuberculosis infections.
Kiev, Ukraine (PRWEB) July 11, 2008 -- Ukrainian company, Ekomed LLC, published clinical study of phytoconcentrates Dzherelo (Immunoxel), Lizorm and Svitanok used as an adjunct immunotherapy against multi-drug (MDR-TB), (XDR-TB), and in patients with concomitant HIV and Mycobacterium tuberculosis infections.
Open-label, salvage anti-tuberculosis therapy (ATT) combined with Dzherelo (Immunoxel), Svitanok, and Lizorm- over-the-counter immunomodulators from medicinal plants - was conducted in 20 Ukrainian patients with late-stage pulmonary TB. In this study seven patients had XDR-TB and the remaining had MDR-TB. Among latter two patients had HIV co-infection but five other AIDS patients had drug-sensitive TB. Patients hospitalized in the TB dispensary were treated under directly observed therapy (DOT) until repeated negative culture conversion and recuperation from radiological and clinical symptoms. The average duration of therapy was 16.2 ± 5.2 weeks (range 10.6-30.3; median 16). The mean time to bacterial clearance was 4.4 ± 1.8 weeks (range 1.3-8.9, median 4.3). All patients (95%), except one, gained weight, ranging between 3-17 kg with average 8.7 kg (P=0.000009). The liver function tests revealed that the level of total bilirubin had improved from 15.5 to 11.6 μmol/L (P=0.009). Alanine transaminase (ALT) came down to normal from 53.1 IU/L to 30.4 IU/L level (P=0.001). Hemoglobin levels increased from 103.2 to 117.3 g/L (P=0.00005). Inflammation-associated, elevated leukocyte counts returned back to normal from 8.9 to 6.9 × 109 cells/L (P=0.003). CD4 T lymphocyte counts in HIV patients have increased from average 371 cells at baseline to 566 cells - an increase equal to 52% (P=0.07). The absolute numbers of CD8+ T-lymphocytes appeared to decline but no statistical significance has been reached (P=0.1). The increase in CD4 cells and decline in CD8 cells resulted in almost doubled ratio of CD4/CD8 cells, i.e., from baseline 0.475 to 0.848 at the end of therapy (P=0.03). Patients recovered clinically and radiologically and were hence discharged from the hospital after 4 months on average.
These findings support prior trials indicating clinical benefit of adding immunomodulators to TB treatment regimens. The combination of ATT with botanical preparations enhances the clinical efficacy of DOT and is safe and beneficial even to patients with poor prognosis due to drug resistance and/or co-infection with HIV. This unique combination results in significantly shortened duration of treatment and is more cost-effective than ATT alone.
Dzherelo, Lizorm and Svitanok are extracts from plants grown in Ukraine that have been used as food or folk medicine since time immemorial. Being derived from botanical sources and with established record of safety they have been approved by the Ministry of Health of Ukraine in 1997 as dietary supplements and as a functional food in 2006.
Over 9 million new cases of TB occur each year worldwide. In the United States alone, it is estimated that 10-15 million people are infected with the TB bacteria and 22,000 new cases occur each year. Tuberculosis is spread from person to person by breathing infected air during close contact. Thus, anyone can get TB.
Despite the overwhelming burden of TB, no new compounds were developed in last 40 years and current strains of TB are becoming resistant to existing drugs. Multidrug-resistant tuberculosis (MDR-TB) refers to organisms that are resistant to at least two of the first-line drugs, Izoniazid and Rifampicin. More recently, extensively (extremely) drug resistant tuberculosis (XDR-TB) has emerged which is resistant to three or more of the second-line treatment drugs. This emerging form of TB caused worldwide concern after recently reported outbreak in Kwazulu Natal province of South Africa where 52 of 53 patients with XDR-TB and HIV had died within 2 weeks from the time of diagnosis. Largely, because of HIV, a tremendous increase in the incidence of TB is seen today and when these two infections are presented in tandem they are more deadly than each one of them alone.
Scientific Director of Ekomed, Mr. Volodymyr Pylypchuk, commented: "Dzherelo and our other botanicals can be useful as immune adjuvants for therapy of tuberculosis and AIDS. What is important is that our study is the first ever study to show that one can treat successfully XDR TB - a condition which is commonly considered to be virtually incurable. In addition to medical problems Ekomed works on ecology projects. We have developed proprietary technologies that can potentially reverse global climate change and reduce greenhouse gas emissions, such as carbon dioxide, in ecologically friendly manner".
About Ekomed LLC
Founded in 1996, Ekomed is a privately-held company based in Kiev, Ukraine. The company is the leading ethnobotanical company that manufactures over 26 different multiherbal preparations for a variety of health disorders. For more details, please visit the company website at www.ekomed.com.ua
Media contact:
Volodymyr Pylypchuk
CEO and Scientific Director
Ekomed LLC
80-A Pravdy Avenue
pylypchuk @ bk.ru www.ekomed.com.ua
You can reprint materials, published in articlesandblogs.ezreklama.com, only if you cite the author of the work and if you provide a direct link to our site. The http://articlesandblogs.ezreklama.com website and services are provided by EZREKLAMA (Manitoba, Canada). The views expressed in the articles, blogs and press releases appearing on this site are those of the writer(s) and do not necessarily reflect the views of EZREKLAMAs' editors and network members. The Editorial staff is entitled to edit the materials.
